Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:42 PM
Ignite Modification Date:
2025-12-24 @ 12:42 PM
NCT ID:
NCT04471961
Eligibility Criteria:
Inclusion Criteria:
* The patient has a solid or haematological malignancy, either familial forms or isolated cases diagnosed between the ages of 0 and 17 years.
* The minor patient and both biological parents are available to participate in the study OR
* The adult patient and one or both parents are available to participate in the study.
* The patient's parents must have given their free and informed consent and signed the consent for the minor's participation in the study.
* The patient's parent(s) must have given free and informed consent and the patient of legal age must have signed the consent for participation in the study.
* The patient must be affiliated or beneficiary of a Frrench social security scheme.
Exclusion Criteria:
* The patient's parents are under guardianship or trusteeship or under legal protection Yes No
* Failure to obtain written informed consent from parents (for themselves and their minor child) after a period of reflection Yes No
* No affiliation to or beneficiary of a French social security scheme (for biological parents and the patient)
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT04471961
Study Brief:
Protocol Section:
NCT04471961